Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T

NeuroImage

Volumn 33, Issue 4, 2006, Pages 1029-1035

  Adhya, Sumita ^a   Johnson, Glyn ^a   Herbert, Joseph ^a   Jaggi, Hina ^a   Babb, James S ^a   Grossman, Robert I ^a   Inglese, Matilde ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROL GROUP; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; DISABILITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FRONTAL CORTEX; GENDER; GROUPS BY AGE; HEMODYNAMICS; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; NEUROIMAGING; OCCIPITAL CORTEX; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION; TREATMENT RESPONSE; VOLUNTEER; WHITE MATTER;

ADULT; AGED; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 33750739263     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.08.008     Document Type: Article

References (44)

1. Adams C.W., Poston R.N., Buk S.J., Sidhu Y.S., and Vipond H. Inflammatory vasculitis in multiple sclerosis. J. Neurol. Sci. 69 (1985) 269-283
2. Adams R.A., Passino M., Sachs B.D., Nuriel T., and Akassoglou K. Fibrin mechanisms and functions in nervous system pathology. Mol. Interv. 4 (2004) 163-176
3. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology 137 (1980) 679-686
4. Bermel R.A., Sharma J., Tjoa C.W., Puli S.R., and Bakshi R. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J. Neurol. Sci. 208 (2003) 57-65
5. Brooks D.J., Leenders K.L., Head G., et al. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 47 (1984) 1182-1191
6. Bruck W., Lucchinetti C., and Lassmann H. The pathology of primary progressive multiple sclerosis. Mult. Scler. 8 (2002) 93-97
7. Calamante F., Gadian D.G., and Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn. Reson. Med. 44 (2000) 466-473
8. Carroll T.J., Rowley H.A., and Haughton V.M. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 227 (2003) 593-600
9. Chang L., Ernst T., Leonido-Yee M., and Speck O. Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 54 (2000) 389-396
10. Evangelou N., Konz D., Esiri M.M., et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123 Pt 9 (2000) 1845-1849
11. Firbank M.J., Colloby S.J., Burn D.J., McKeith I.G., and O'Brien J.T. Regional cerebral blood flow in Parkinson's disease with and without dementia. NeuroImage 20 (2003) 1309-1319
12. Haselhorst R., Kappos L., Bilecen D., et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J. Magn. Reson. Imaging 11 (2000) 495-505
13. Hauser S.L. Multiple sclerosis and other demyelinating diseases. In: Isselbacher K.J.W.J., Martin J.B., Fauci A.S., and Kasper D.L. (Eds). Harrison's Principles of Internal Medicine (1994), McGraw-Hill, New York 2287-2295
14. Ingle G.T., Sastre-Garriga J., Miller D.H., and Thompson A.J. Is inflammation important in early PPMS? A longitudinal MRI study. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1255-1258
15. Johnson N.A., Jahng G.H., Weiner M.W., et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234 (2005) 851-859
16. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
17. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J. Neurol. Sci. 206 (2003) 187-191
18. Latchaw R.E. Cerebral perfusion imaging in acute stroke. J. Vasc. Interv. Radiol. 15 (2004) S29-S46
19. Law M., Saindane A.M., Ge Y., et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231 (2004) 645-652
20. Leary S.M., and Thompson A.J. Interferon beta-1a in primary progressive multiple sclerosis. J. Neurol. Sci. 206 (2003) 215-216
21. Loevner L.A., Grossman R.I., Cohen J.A., et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 196 (1995) 511-515
22. Lycke J., Wikkelso C., Bergh A.C., Jacobsson L., and Andersen O. Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime. Eur. Neurol. 33 (1993) 163-167
23. Manka C., Traber F., Gieseke J., Schild H.H., and Kuhl C.K. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. Radiology 234 (2005) 869-877
24. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
25. Miller D.H., Thompson A.J., and Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J. Neurol. 250 (2003) 1407-1419
26. Noseworthy J.H. Progress in determining the causes and treatment of multiple sclerosis. Nature 399 (1999) A40-A47
27. Pozzilli C., Passafiume D., Bernardi S., et al. SPECT, MRI and cognitive functions in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 54 (1991) 110-115
28. Putnam T. The pathogenesis of multiple sclerosis: a possible vascular factor. N. Engl. J. Med. 209 (1933) 786-790
29. Putnam T. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch. Neurol. Neuropsychol. 32 (1935) 1298-1321
30. Rashid W., Parkes L.M., Ingle G.T., et al. Abnormalities of cerebral perfusion in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1288-1293
31. Rempp K.A., Brix G., Wenz F., et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193 (1994) 637-641
32. Rosen B.R., Belliveau J.W., Buchbinder B.R., et al. Contrast agents and cerebral hemodynamics. Magn. Reson. Med. 19 (1991) 285-292
33. Rovaris M., Gallo A., Falini A., et al. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. Arch. Neurol. 62 (2005) 898-902
34. Rovaris M., Gass A., Bammer R., et al. Diffusion MRI in multiple sclerosis. Neurology 65 (2005) 1526-1532
35. Rudick R.A. Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics. Arch. Neurol. 56 (1999) 1079-1084
36. Thompson A.J., Kermode A.G., Wicks D., et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann. Neurol. 29 (1991) 53-62
37. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
38. Trapp B.D., Ransohoff R., and Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12 (1999) 295-302
39. Wakefield A.J., More L.J., Difford J., and McLaughlin J.E. Immunohistochemical study of vascular injury in acute multiple sclerosis. J. Clin. Pathol. 47 (1994) 129-133
40. Warach S., Levin J.M., Schomer D.L., Holman B.L., and Edelman R.R. Hyperperfusion of ictal seizure focus demonstrated by MR perfusion imaging. AJNR Am. J. Neuroradiol. 15 (1994) 965-968
41. Wetzel S.G., Cha S., Johnson G., et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 224 (2002) 797-803
42. Wolinsky J.S. The use of glatiramer acetate in the treatment of multiple sclerosis. Adv. Neurol. 98 (2006) 273-292
43. Wuerfel J., Bellmann-Strobl J., Brunecker P., et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 127 (2004) 111-119
44. Zettl U.K., Kuhlmann T., and Bruck W. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 24 (1998) 202-208